Transcriptomics Market

Segmentation by Technology (Microarray, Real-time PCR, Sequencing Technology, and Others); by Application (Clinical Diagnostics, Drug Discovery, and Others); and by End User (Clinical Research Centers, Hospitals, Specialty Clinics, and Others) – Global Demand Analysis & Opportunity Outlook 2031

Buy Now
Report ID: 3935 | Published On: Feb 06, 2023
Request Free Sample Copy

Global Transcriptomics Market Regional Synopsis

On the basis of geographical analysis, the global transcriptomics market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in Asia Pacific region is estimated to witness noteworthy growth over the forecast period on the back of advancements in the healthcare sector, backed by rising healthcare expenditure across the region.

The market in the North America region is anticipated to gain the largest market share throughout the forecast period owing to the rapidly developing biotech and diagnostic industry in the developed countries. For instance, in the U.S. around USD 100 billion were invested in biotech companies, in 2020. Moreover, the growing prevalence of rare cancers in the region is also estimated to boost the market growth. According to the data by the American Cancer Society, in the United States, about 60,650 new cases of leukemia were reported in 2021, with over 24,000 deaths caused from all kind of leukemia.

Transcriptomics Market Share

The global transcriptomics market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

Transcriptomics Market
Get more information on this report: Request Sample PDF

Major Macro-Economic Indicators Impacting the Market Growth

Healthcare Expenditure per Capita, (USD), 2015-2018

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Market Segmentation

Our in-depth analysis of the global transcriptomics market includes the following segments:

By Technology

  • Microarray
  • Real-time PCR
  • Sequencing Technology
  • Others

By Application

  • Clinical Diagnostics
  • Drug Discovery
  • Others

By End-User

  • Clinical Research Centers
  • Hospitals
  • Specialty Clinics
  • Others

Growth Drivers

  • Increasing Prevalence of Cancer
  • Increasing Demand for Personalized Medicines
  • Growing Investment in the R&D Activities


  • Lack of Skilled Professionals
  • Few Drawbacks of RNA Sequencing

Healthcare Expenditure per Capita, (USD), 2015-2018
Get more information on this report: Request Sample PDF

Top Featured Companies Dominating the Market

    • Thermo Fisher Scientific Company
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis 
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.
    • CD Genomics
    • F. Hoffmann-La Roche AG
    • GenXPro GmbH
    • Qiagen N.V.
    • Illumina, Inc.
    • The Merck Group
    • Siemens AG

In The News

  • November, 2021: Thermo Fisher Scientific Company launched new IVD system for assay developers and clinical laboratories to facilitate molecular diagnostics growth.

  • March, 2021:  CD Genomics launched the low-coverage sequencing which can effectively identify novel variants in the genomic databases.

Global Economic Impact

Request Insights
Despite Inflation & Fearing Recession, Businesses Across the Globe Expected to Do Better in 2023:

In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.

Key Questions Answered in the Report

1) What are the major factors driving the growth of the transcriptomics market?

Ans: Increasing personalized approach towards treatment of rare diseases is estimated to boost the market growth.

2) What would be the CAGR of transcriptomics market over the forecast period?

Ans: The market is anticipated to attain a CAGR of ~14% over the forecast period, i.e., 2022 – 2031.

5) Who are the major players dominating the transcriptomics market?

Ans: The major players in the market are Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., CD Genomics, F. Hoffmann-La Roche AG, GenXPro GmbH, Qiagen N.V., Illumina, Inc., The Merck Group, Siemens AG, and others.

6) How are the company profiles selected?

Ans: The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

7) What are the segments in the transcriptomics market?

Ans: The market is segmented by technology, application, end-user, and by region.

8) Which segment captures the largest market size in technology segment in the transcriptomics market?

Ans: The real-time PCR segment is anticipated to hold largest market over the forecast period and display significant growth opportunities.

8) What are the challenges affecting the market growth?

Ans: The low availability of skilled researchers is estimated to hamper the market growth.

8) Which region will provide more business opportunities for growth of the transcriptomics market in future?

Ans: The market in the North America region is estimated to provide more business opportunities for growth over the forecast period owing to the advancement in technology in the healthcare sector.

Let Us Hear About Your Requirements:

Submit Your Request For Proposal (RFP)

Request Research Report Sample